On the public citation graph

Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients

https://doi.org/10.1681/asn.2021040490
0 signed · 182 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2021.4385openalex-snapshot
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
inferredcites →https://doi.org/10.1001/jama.2021.7489openalex-snapshot
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
inferredcites →https://doi.org/10.1007/s10157-018-1676-xopenalex-snapshot
Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast anatolia survey with six hemodialysis centers
inferredcites →https://doi.org/10.1016/j.cell.2020.12.015openalex-snapshot
COVID-19 Neutralizing Antibodies Predict Disease Severity and Survival
inferredcites →https://doi.org/10.1016/j.kint.2021.04.005openalex-snapshot
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine
inferredcites →https://doi.org/10.1016/j.nephro.2017.11.007openalex-snapshot
Vaccinations des patients adultes atteints d’une maladie rénale
inferredcites →https://doi.org/10.1038/nrneph.2013.44openalex-snapshot
Immune cell dysfunction and inflammation in end-stage renal disease
inferredcites →https://doi.org/10.1038/s41586-020-2639-4openalex-snapshot
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
inferredcites →https://doi.org/10.1053/j.ajkd.2019.06.014openalex-snapshot
Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney Transplantation
inferredcites →https://doi.org/10.1056/nejmclde2101987openalex-snapshot
Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination
inferredcites →https://doi.org/10.1056/nejmoa2027906openalex-snapshot
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
inferredcites →https://doi.org/10.1056/nejmoa2034577openalex-snapshot
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
inferredcites →https://doi.org/10.1111/ajt.16615openalex-snapshot
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus
inferredcites →https://doi.org/10.1111/j.1525-139x.2004.17104.xopenalex-snapshot
The Value of Vaccination in Chronic Kidney Disease
inferredcites →https://doi.org/10.1159/000063553openalex-snapshot
Humoral Immune Responses in Uremia and the Role of IL-10
inferredcites →https://doi.org/10.1172/jci141206openalex-snapshot
Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization
inferredcites →https://doi.org/10.2215/cjn.03500321openalex-snapshot
Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis
inferredcites →https://doi.org/10.3390/toxins12050300openalex-snapshot
Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4809770openalex-extracted
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.31749openalex-snapshot
Immunogenicity Rates After SARS-CoV-2 Vaccination in People With End-stage Kidney Disease
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2022.6822openalex-snapshot
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant
inferred← citeshttps://doi.org/10.1002/cpt.2872openalex-snapshot
Mycophenolic Acid Exposure Determines Antibody Formation Following SARS‐CoV ‐2 Vaccination in Kidney Transplant Recipients: A Nested Cohort Study
inferred← citeshttps://doi.org/10.1002/cti2.1411openalex-snapshot
Previous SARS‐CoV ‐2 infection or a third dose of vaccine elicited cross‐variant neutralising antibodies in vaccinated solid‐organ transplant recipients
inferred← citeshttps://doi.org/10.1002/cti2.1523openalex-snapshot
Serological responses and clinical outcomes following a three‐dose primary COVID‐19 vaccine schedule in kidney transplant recipients and people on dialysis
inferred← citeshttps://doi.org/10.1002/hsr2.700openalex-snapshot
Safety and efficacy of coronavirus disease‐19 vaccines in chronic kidney disease patients under maintenance hemodialysis: A systematic review
inferred← citeshttps://doi.org/10.1002/hsr2.874openalex-snapshot
Immunogenicity of COVID‐19 mRNA vaccines in hemodialysis patients: Systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1002/jmv.27714openalex-snapshot
Short and mid‐term SARS‐CoV‐2 antibody response after inactivated COVID‐19 vaccine in hemodialysis and kidney transplant patients
inferred← citeshttps://doi.org/10.1002/rmv.2359openalex-snapshot
Recent developments in SARS‐CoV‐2 vaccines: A systematic review of the current studies
inferred← citeshttps://doi.org/10.1007/978-981-19-6909-6_20openalex-snapshot
How to Manage Children with Chronic Kidney Allograft Dysfunction
inferred← citeshttps://doi.org/10.1007/s00467-022-05511-7openalex-snapshot
Considering a COVID-19 vaccine mandate for pediatric kidney transplant candidates
inferred← citeshttps://doi.org/10.1007/s00467-022-05679-yopenalex-snapshot
Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients
inferred← citeshttps://doi.org/10.1007/s10096-023-04701-xopenalex-snapshot
Longevity of the humoral and cellular responses after SARS-CoV-2 booster vaccinations in immunocompromised patients
inferred← citeshttps://doi.org/10.1007/s10157-021-02151-3openalex-snapshot
Effectiveness of neutralizing antibody cocktail in hemodialysis patients: a case series of 20 patients treated with or without REGN-COV2
inferred← citeshttps://doi.org/10.1007/s10157-022-02243-8openalex-snapshot
SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan
inferred← citeshttps://doi.org/10.1007/s10157-023-02334-0openalex-snapshot
Antibody acquisition after second and third SARS-CoV-2 vaccinations in Japanese kidney transplant patients: a prospective study
inferred← citeshttps://doi.org/10.1007/s10157-023-02342-0openalex-snapshot
Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis
inferred← citeshttps://doi.org/10.1007/s11255-023-03496-2openalex-snapshot
Clinical features, management and outcomes of peritoneal dialysis patients during Delta and Omicron waves of COVID-19 infections
inferred← citeshttps://doi.org/10.1007/s11255-023-03706-xopenalex-snapshot
Chronic kidney disease in the shadow of COVID-19: insights from the bibliometric analysis
inferred← citeshttps://doi.org/10.1007/s11560-021-00528-9openalex-snapshot
Update zu: Erfahrungen aus dem deutschen COVID-19-Register
inferred← citeshttps://doi.org/10.1007/s12603-023-1994-xopenalex-snapshot
Frailty and Humoral Immune Responses Following COVID-19 Vaccination among Patients Undergoing Hemodialysis
inferred← citeshttps://doi.org/10.1007/s40264-021-01131-6openalex-snapshot
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety
inferred← citeshttps://doi.org/10.1007/s40472-022-00366-1openalex-snapshot
COVID-19 Vaccine Efficacy and Immunogenicity in End-Stage Renal Disease Patients and Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.1007/s40620-023-01640-wopenalex-snapshot
What has vaccination against COVID-19 in CKD patients taught us?
inferred← citeshttps://doi.org/10.1007/s40620-023-01650-8openalex-snapshot
Kinetics of humoral immune response and severity of infection after three doses of SARS-CoV-2 mRNA vaccine in a large cohort of kidney transplant recipients
inferred← citeshttps://doi.org/10.1007/s40746-023-00267-0openalex-snapshot
Practical Approaches to Management of Children With COVID-19 and Kidney Disease: the Known, Unknown, and the Future
inferred← citeshttps://doi.org/10.1007/s42000-022-00365-yopenalex-snapshot
Immunosuppressed non-responders to two doses of mRNA SARS-CoV-2 vaccines achieve an immune response comparable to those of immunocompetent individuals after a third dose
inferred← citeshttps://doi.org/10.1016/j.banm.2022.01.025openalex-snapshot
COVID-19 et transplantation d’organes, les leçons du recensement national de la Société francophone de transplantation
inferred← citeshttps://doi.org/10.1016/j.cmi.2021.09.036openalex-snapshot
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
inferred← citeshttps://doi.org/10.1016/j.cmi.2022.12.004openalex-snapshot
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2024.116550openalex-snapshot
Attenuated neutralization, maintained specificity: Humoral response to SARS-CoV-2 booster in kidney allograft recipients
inferred← citeshttps://doi.org/10.1016/j.ekir.2022.09.005openalex-snapshot
Improved Immune Response to the Third COVID-19 mRNA Vaccine Dose in Hemodialysis Patients
inferred← citeshttps://doi.org/10.1016/j.heliyon.2025.e42291openalex-snapshot
Impact of immunosuppressive regimens on antibody response after COVID-19 vaccination among Thai kidney transplant recipients
inferred← citeshttps://doi.org/10.1016/j.jinf.2021.12.035openalex-snapshot
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.kint.2021.07.017openalex-snapshot
Should vaccination against COVID-19 be mandated in patients on the transplant waiting list?
inferred← citeshttps://doi.org/10.1016/j.kint.2021.10.040openalex-snapshot
A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis
inferred← citeshttps://doi.org/10.1016/j.kint.2021.12.015openalex-snapshot
REGEN-Cov antibody combination to prevent COVID-19 infection in kidney transplant recipient without detectable antibody response to optimal vaccine scheme
inferred← citeshttps://doi.org/10.1016/j.lpm.2022.104146openalex-snapshot
COVID-19 and kidney transplantation
inferred← citeshttps://doi.org/10.1016/j.nmni.2024.101458openalex-snapshot
Cellular and humoral response to SARS-CoV-2 vaccine BNT162b2 in adults with Chronic Kidney Disease G4/5.
inferred← citeshttps://doi.org/10.1016/j.transproceed.2023.02.018openalex-snapshot
Comparison of Humoral Response in Kidney Transplant Recipients and Donors and Healthy Volunteers Following Second Dose of SARS-CoV-2 mRNA Vaccine
inferred← citeshttps://doi.org/10.1016/j.transproceed.2023.09.031openalex-snapshot
Chronological Changes in Emotional Status and Vaccine Implementation Rate Among Patients on the Waiting List for Deceased-Donor Kidney Transplantation During the Prolonged COVID-19 Pandemic
inferred← citeshttps://doi.org/10.1016/j.trim.2022.101713openalex-snapshot
Comparative analysis of humoral responses to BNT162b2 vaccine among patients with hematologic disorders and organ transplant recipients.
inferred← citeshttps://doi.org/10.1016/j.trre.2022.100710openalex-snapshot
COVID-19 and solid organ transplantation: Finding the right balance
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.126544openalex-snapshot
COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients
inferred← citeshttps://doi.org/10.1017/ash.2022.31openalex-snapshot
Predictors of humoral response to SARS-CoV-2 mRNA vaccine BNT162b2 in patients receiving maintenance dialysis
inferred← citeshttps://doi.org/10.1038/s41467-022-32371-4openalex-snapshot
A CRISPR-based ultrasensitive assay detects attomolar concentrations of SARS-CoV-2 antibodies in clinical samples
inferred← citeshttps://doi.org/10.1038/s41598-022-09897-0openalex-snapshot
Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients
inferred← citeshttps://doi.org/10.1038/s41598-022-12750-zopenalex-snapshot
Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine
inferred← citeshttps://doi.org/10.1038/s41598-023-42406-5openalex-snapshot
Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab
inferred← citeshttps://doi.org/10.1038/s41598-024-76251-xopenalex-snapshot
Impaired SARS-CoV-2-specific responses via activated T follicular helper cells in immunocompromised kidney transplant recipients
inferred← citeshttps://doi.org/10.1053/j.ajkd.2022.10.010openalex-snapshot
SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis
inferred← citeshttps://doi.org/10.1055/s-0041-1740110openalex-snapshot
COVID-19 in Immunocompromised Patients: A Systematic Review
inferred← citeshttps://doi.org/10.1080/10408363.2022.2038539openalex-snapshot
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review
inferred← citeshttps://doi.org/10.1080/21505594.2024.2351266openalex-snapshot
Humoral responses to multiple SARS-CoV-2 variants after two doses of vaccine in kidney transplant patients
inferred← citeshttps://doi.org/10.1080/21645515.2023.2196893openalex-snapshot
A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients
inferred← citeshttps://doi.org/10.1093/ckj/sfab152openalex-snapshot
Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis
inferred← citeshttps://doi.org/10.1093/ckj/sfab206openalex-snapshot
Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose
inferred← citeshttps://doi.org/10.1093/ckj/sfab221openalex-snapshot
Humoral responses to BNT162b2 SARS-CoV-2 and hepatitis B vaccines are associated in patients on maintenance hemodialysis: a single-centre experience in Belgium
inferred← citeshttps://doi.org/10.1093/ckj/sfab291openalex-snapshot
Comparison of antibody response to SARS-CoV-2 after two doses of inactivated virus and BNT162b2 mRNA vaccines in kidney transplant
inferred← citeshttps://doi.org/10.1093/ckj/sfac093openalex-snapshot
Dynamics of SARS-CoV-2-Spike-reactive antibody and T-cell responses in chronic kidney disease patients within 3 months after COVID-19 full vaccination
inferred← citeshttps://doi.org/10.1093/ckj/sfac166openalex-snapshot
BNT162b2 vaccine effectiveness in chronic kidney disease patients—an observational study
inferred← citeshttps://doi.org/10.1093/ndt/gfab321openalex-snapshot
Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients
inferred← citeshttps://doi.org/10.1093/ndt/gfac018openalex-snapshot
Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies
inferred← citeshttps://doi.org/10.1093/ndt/gfac052openalex-snapshot
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS
inferred← citeshttps://doi.org/10.1093/ndt/gfad063c_3385openalex-snapshot
#3385 A STUDY OF CLINICAL SPECTRUM AND THE OUTCOME IN LIVE KIDNEY TRANSPLANT RECIPIENTS IN A TERTIARY CARE CENTRE OF INDIA
inferred← citeshttps://doi.org/10.1093/ndt/gfad063c_5280openalex-snapshot
#5280 PREVALENCE OF POLYPHARMACY AND ASSOCIATED ADVERSE OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS
inferred← citeshttps://doi.org/10.1097/tp.0000000000004044openalex-snapshot
Determinants of Immune Response to Anti–SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients: A Prospective Cohort Study
inferred← citeshttps://doi.org/10.1111/ajt.16990openalex-snapshot
Predictive factors of a viral neutralizing humoral response after a third dose of COVID-19 mRNA vaccine
inferred← citeshttps://doi.org/10.1111/hdi.13011openalex-snapshot
Humoral antibody response to the first dose of the ChAdOx1 nCoV ‐19 vaccine in Asian patients undergoing hemodialysis
inferred← citeshttps://doi.org/10.1111/iju.14882openalex-snapshot
Effect of active anticancer therapy on serologic response to SARS‐CoV‐2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma
inferred← citeshttps://doi.org/10.1111/nep.13974openalex-snapshot
Humoral and cellular immune response to severe acute respiratory syndrome coronavirus‐2 vaccination in haemodialysis and kidney transplant patients
inferred← citeshttps://doi.org/10.1111/sdi.13229openalex-snapshot
Increase of Hepatitis B Surface Antibody Levels After Inactivated COVID‐19 Vaccine in Hemodialysis Patients: An Important Single‐Center Observation
inferred← citeshttps://doi.org/10.1111/tid.13740openalex-snapshot
Antibody response to two doses of inactivated SARS‐CoV‐2 vaccine (CoronaVac) in kidney transplant recipients
inferred← citeshttps://doi.org/10.1111/tid.13926openalex-snapshot
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1128/spectrum.03445-22openalex-snapshot
Trajectory of Humoral Responses to Two Doses of ChAdOx1 nCoV-19 Vaccination in Patients Receiving Maintenance Hemodialysis
inferred← citeshttps://doi.org/10.1136/bmj-2021-068632openalex-snapshot
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1159/000525519openalex-snapshot
Humoral Response to the Third Dose of BNT162b2 COVID-19 Vaccine among Hemodialysis Patients
inferred← citeshttps://doi.org/10.1186/s12879-022-07809-1openalex-snapshot
Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients
inferred← citeshttps://doi.org/10.1186/s12879-023-08620-2openalex-snapshot
In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the omicron variant of SARS-CoV-2: a single-center retrospective study
inferred← citeshttps://doi.org/10.1186/s12882-024-03789-3openalex-snapshot
Determinants of protective humoral response to mRNA-1273 and BNT162b2 vaccines in peritoneal dialysis patients: a prospective cohort study
inferred← citeshttps://doi.org/10.1186/s12882-025-04264-3openalex-snapshot
Chronic heart failure and hypoalbuminemia are risk factors of poorer mRNA SARS-CoV-2 vaccine response in maintenance Hemodialysis patients (the COVaccinDia study)
inferred← citeshttps://doi.org/10.1186/s12979-022-00288-7openalex-snapshot
Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity
inferred← citeshttps://doi.org/10.1186/s12985-022-01858-3openalex-snapshot
Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1186/s13023-022-02386-7openalex-snapshot
COVID-19 in Fabry disease: a reference center prospective study
inferred← citeshttps://doi.org/10.12688/f1000research.122820.1openalex-snapshot
A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individuals
inferred← citeshttps://doi.org/10.1371/journal.pone.0263328openalex-snapshot
Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients
inferred← citeshttps://doi.org/10.1371/journal.pone.0265130openalex-snapshot
Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre
inferred← citeshttps://doi.org/10.1371/journal.pone.0281160openalex-snapshot
Outcomes of vaccinations against respiratory diseases in patients with end-stage renal disease undergoing hemodialysis: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.15557/pimr.2024.0026openalex-snapshot
Long-term immune response and antibody dynamics after SARS-CoV-2 vaccination in patients undergoing renal replacement therapy
inferred← citeshttps://doi.org/10.1590/2175-8239-jbn-2022-0184enopenalex-snapshot
Assessment of humoral immune response to different COVID-19 vaccines in patients undergoing maintenance hemodialysis
inferred← citeshttps://doi.org/10.1590/2175-8239-jbn-2022-0184ptopenalex-snapshot
Avaliação da resposta imune humoral a diferentes vacinas contra a COVID-19 em pacientes submetidos à hemodiálise de manutenção
inferred← citeshttps://doi.org/10.1590/2175-8239-jbn-2025-0206enopenalex-snapshot
Kinetics of cellular immune response to SARS-CoV-2 vaccine boosters in dialysis and kidney transplant patients without infection
inferred← citeshttps://doi.org/10.1590/2175-8239-jbn-2025-0206ptopenalex-snapshot
Cinética da resposta imune celular à vacina contra SARS-CoV-2 em diálise e transplante renal sem infecção
inferred← citeshttps://doi.org/10.1681/asn.0000000000000251openalex-snapshot
The COVID-19 Pandemic: A Special Challenge for the Journal's Editors
inferred← citeshttps://doi.org/10.1681/asn.2021070966openalex-snapshot
B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.17219/acem/147360openalex-snapshot
Factors predictive of anti-spike antibody titers after COVID-19 vaccination in hemodialysis patients
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1120488/v1openalex-snapshot
Seroprevalence of SARS-CoV-2 IgG Antibodies After the Second BNT162b2 mRNA Vaccine in Japanese Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1125353/v1openalex-snapshot
Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population; A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1165368/v1openalex-snapshot
Changes in Spike Protein Antibody Titer Over 90 Days after the Second Dose of SARS- CoV-2 Vaccine in Japanese Dialysis Patients
inferred← citeshttps://doi.org/10.2215/cjn.11820921openalex-snapshot
Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 Vaccination
inferred← citeshttps://doi.org/10.2215/cjn.12250921openalex-snapshot
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months
inferred← citeshttps://doi.org/10.2491/jjsth.32.726openalex-snapshot
COVID-19 and kidney disease
inferred← citeshttps://doi.org/10.26508/lsa.202201381openalex-snapshot
mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients
inferred← citeshttps://doi.org/10.29011/2575-7903.001303openalex-snapshot
SARS-CoV-2 Antibodies in Patients on Hemodialysis after the BNT162b2 mRNA Vaccination
inferred← citeshttps://doi.org/10.3389/fimmu.2022.1017178openalex-snapshot
Ferric carboxymaltose and SARS-CoV-2 vaccination-induced immunogenicity in kidney transplant recipients with iron deficiency: The COVAC-EFFECT randomized controlled trial
inferred← citeshttps://doi.org/10.3389/fimmu.2022.1033770openalex-snapshot
SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients
inferred← citeshttps://doi.org/10.3389/fimmu.2022.1083167openalex-snapshot
Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation
inferred← citeshttps://doi.org/10.3389/fimmu.2022.894700openalex-snapshot
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response After Heterologous Immunizations With ChAdOx1/BNT162b2 in End-Stage Renal Disease Patients on Hemodialysis
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1202630openalex-snapshot
Low switched memory B cells are associated with no humoral response after SARS-CoV-2 vaccine boosters in kidney transplant recipients
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1586468openalex-snapshot
Comparison of SARS-CoV-2 IgG responses in hemodialysis patients and healthcare workers after COVID-19 vaccination
inferred← citeshttps://doi.org/10.3389/fmed.2021.746644openalex-snapshot
SARS-CoV-2 Infection in Fully Vaccinated Individuals of Old Age Strongly Boosts the Humoral Immune Response
inferred← citeshttps://doi.org/10.3389/fmed.2021.796676openalex-snapshot
Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up
inferred← citeshttps://doi.org/10.3389/fmed.2022.818882openalex-snapshot
B Cell Composition Is Altered After Kidney Transplantation and Transitional B Cells Correlate With SARS-CoV-2 Vaccination Response
inferred← citeshttps://doi.org/10.3389/fmed.2022.827859openalex-snapshot
Immunogenicity and Safety of COVID-19 Vaccines in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.3389/fmed.2022.927546openalex-snapshot
Humoral Response Following Triple Dose of mRNA Vaccines Against SARS-CoV-2 in Hemodialysis Patients: Results After 1 Year of Follow-Up
inferred← citeshttps://doi.org/10.3389/fphar.2021.710543openalex-snapshot
mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
inferred← citeshttps://doi.org/10.3389/fpubh.2022.951096openalex-snapshot
Immunogenicity and safety of SARS-CoV-2 vaccine in hemodialysis patients: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.3389/frtra.2024.1305152openalex-snapshot
Adequacy to immunosuppression management guidelines in kidney transplant recipients with severe COVID-19 pneumonia: a practice survey
inferred← citeshttps://doi.org/10.3389/ti.2022.10716openalex-snapshot
Kidney Transplantation in Patients With Active SARS-CoV-2 Replication: An Initial Case Series
inferred← citeshttps://doi.org/10.3390/app12126103openalex-snapshot
Effectiveness and Safety of ANTI SARS-CoV-2 Vaccination in Transplant Patients Treated with Immunosuppressants: A Real-World Pilot Study with a 1-Year Follow-Up
inferred← citeshttps://doi.org/10.3390/biomedicines10030636openalex-snapshot
SARS-CoV-2 mRNA Vaccine-Induced Cellular and Humoral Immunity in Hemodialysis Patients
inferred← citeshttps://doi.org/10.3390/idr14060093openalex-snapshot
Immunogenicity of the Two mRNA SARS-CoV-2 Vaccines in a Large Cohort of Dialysis Patients
inferred← citeshttps://doi.org/10.3390/ijerph191610091openalex-snapshot
Vaccination against SARS-CoV-2 in Haemodialysis Patients: Spike’s Ab Response and the Influence of BMI and Age
inferred← citeshttps://doi.org/10.3390/jcm10214833openalex-snapshot
Comparing Humoral and Cellular Adaptive Immunity during Convalescent Phase of COVID-19 in Hemodialysis Patients and Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.3390/jcm10215113openalex-snapshot
Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study
inferred← citeshttps://doi.org/10.3390/jcm11010064openalex-snapshot
Waning Humoral Response 3 to 6 Months after Vaccination with the SARS-COV-2 BNT162b2 mRNA Vaccine in Dialysis Patients
inferred← citeshttps://doi.org/10.3390/jcm12031225openalex-snapshot
Cellular and Humoral Responses to Recombinant and Inactivated SARS-CoV-2 Vaccines in CKD Patients: An Observational Study
inferred← citeshttps://doi.org/10.3390/jcm12093172openalex-snapshot
Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers
inferred← citeshttps://doi.org/10.3390/jpm11080789openalex-snapshot
COVID-19 Vaccines in Patients with Maintenance Hemodialysis
inferred← citeshttps://doi.org/10.3390/jpm12010068openalex-snapshot
Neutralization Assessments Reveal High Cardiothoracic Ratio and Old Age as Independent Predictors of Low Neutralizing Antibody Titers in Hemodialysis Patients Receiving a Single Dose of COVID-19 Vaccine
inferred← citeshttps://doi.org/10.3390/medicina57121327openalex-snapshot
Immune Response after SARS-CoV-2 Vaccination in Kidney Transplant Patients
inferred← citeshttps://doi.org/10.3390/microorganisms10051021openalex-snapshot
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort
inferred← citeshttps://doi.org/10.3390/microorganisms9122622openalex-snapshot
Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant
inferred← citeshttps://doi.org/10.3390/pathogens11070800openalex-snapshot
RNA Viruses, Pregnancy and Vaccination: Emerging Lessons from COVID-19 and Ebola Virus Disease
inferred← citeshttps://doi.org/10.3390/vaccines10020327openalex-snapshot
Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis
inferred← citeshttps://doi.org/10.3390/vaccines10091460openalex-snapshot
Antibody Response and Adverse Events of AZD1222 COVID-19 Vaccination in Patients Undergoing Dialysis: A Prospective Cohort Study
inferred← citeshttps://doi.org/10.3390/vaccines10101670openalex-snapshot
Humoral Response to Hepatitis B and COVID-19 Vaccine among Maintenance Hemodialysis Patients
inferred← citeshttps://doi.org/10.3390/vaccines10111911openalex-snapshot
COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.3390/vaccines11040715openalex-snapshot
Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study
inferred← citeshttps://doi.org/10.3390/vaccines11040724openalex-snapshot
Humoral Response in Hemodialysis Patients Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review of Literature
inferred← citeshttps://doi.org/10.3390/vaccines11051012openalex-snapshot
A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients
inferred← citeshttps://doi.org/10.3390/vaccines11071141openalex-snapshot
The Humoral Response to SARS-CoV-2 Vaccine in Hemodialysis Patients Is Correlated with Nutritional Status
inferred← citeshttps://doi.org/10.3390/vaccines11101584openalex-snapshot
Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients
inferred← citeshttps://doi.org/10.3390/vaccines12010091openalex-snapshot
Differences in Responses of Immunosuppressed Kidney Transplant Patients to Moderna mRNA-1273 versus Pfizer-BioNTech
inferred← citeshttps://doi.org/10.3390/vaccines9101055openalex-snapshot
Antibody Responses after a Third Dose of COVID-19 Vaccine in Kidney Transplant Recipients and Patients Treated for Chronic Lymphocytic Leukemia
inferred← citeshttps://doi.org/10.3390/vaccines9121424openalex-snapshot
Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study
inferred← citeshttps://doi.org/10.37551/s2254-28842021020openalex-snapshot
COVID-19 en receptores de trasplante renal: ¿qué hemos aprendido tras 18 meses de pandemia?
inferred← citeshttps://doi.org/10.4009/jsdt.56.101openalex-snapshot
Questionnaire Survey on Vaccination Status and Reasons for Non-immunization with the Novel Coronavirus Vaccine among Dialysis Facility Workers in Okinawa Prefecture
inferred← citeshttps://doi.org/10.4103/ijn.ijn_291_22openalex-snapshot
Humoral Immune Response to BBV152 (Covaxin) SARS-CoV-2 Vaccine in Patients on Hemodialysis
inferred← citeshttps://doi.org/10.4103/sjkdt.sjkdt_606_21openalex-snapshot
A Prospective Single-center Study Assessing the Immunogenicity of Oxford–AstraZeneca Vaccine in Maintenance Hemodialysis Patients
inferred← citeshttps://doi.org/10.5500/wjt.v16.i2.119075openalex-snapshot
Clinical predictors of SARS-CoV-2 vaccine immunogenicity in kidney transplant recipients at a rural center
inferred← citeshttps://doi.org/10.6002/ect.2022.0261openalex-snapshot
A Comparative Study on the Variation in Seropositivity Rates After 2-Dose COVID-19 Vaccination Before or After Transplant: A Single-Center Analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.20176118openalex-snapshot
Additional file 1 of COVID-19 in Fabry disease: a reference center prospective study
inferred← citeshttps://doi.org/10.6084/m9.figshare.20452896openalex-snapshot
Additional file 1 of Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.21557274openalex-snapshot
Additional file 1 of Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients
inferred← citeshttps://doi.org/10.6084/m9.figshare.21557277openalex-snapshot
Additional file 2 of Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients
inferred← citeshttps://doi.org/10.6084/m9.figshare.21557280openalex-snapshot
Additional file 3 of Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients
inferred← citeshttps://doi.org/10.6084/m9.figshare.21557283openalex-snapshot
Additional file 4 of Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients
inferred← citeshttps://doi.org/10.6084/m9.figshare.21557286openalex-snapshot
Additional file 5 of Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients
inferred← citeshttps://doi.org/10.6084/m9.figshare.21557289openalex-snapshot
Additional file 6 of Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients
inferred← citeshttps://doi.org/10.6084/m9.figshare.21557292openalex-snapshot
Additional file 7 of Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients
inferred← citeshttps://doi.org/10.6084/m9.figshare.24354993openalex-snapshot
Additional file 1 of In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the omicron variant of SARS-CoV-2: a single-center retrospective study
inferred← citeshttps://doi.org/10.7774/cevr.2023.12.1.13openalex-snapshot
Seroconversion rates in kidney transplant recipients following SARS-CoV-2 vaccination and its association with immunosuppressive agents: a systematic review and meta-analysis
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.